This could partly account for why we failed to find the genetic contribution of FOXO3 to T2DM, obesity and metabolic syndrome, possibly because of the minor effect of FOXO3 variants which is insufficient for the threshold of a disease. This evidence concerns the gene FOXO3 and Obesity.